IBDEI1F7.m

IBDEI1F7 ; ; 01-FEB-2022

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,22975,1,3,0)

 ;;=3^Purpura,Hemorrhagic Condition

 ;;^UTILITY(U,$J,358.3,22975,1,4,0)

 ;;=4^D69.8

 ;;^UTILITY(U,$J,358.3,22975,2)

 ;;=^88074

 ;;^UTILITY(U,$J,358.3,22976,0)

 ;;=L08.9^^76^992^28

 ;;^UTILITY(U,$J,358.3,22976,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22976,1,3,0)

 ;;=3^Pyoderma

 ;;^UTILITY(U,$J,358.3,22976,1,4,0)

 ;;=4^L08.9

 ;;^UTILITY(U,$J,358.3,22976,2)

 ;;=^5009082

 ;;^UTILITY(U,$J,358.3,22977,0)

 ;;=L01.00^^76^992^29

 ;;^UTILITY(U,$J,358.3,22977,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22977,1,3,0)

 ;;=3^Impetigo

 ;;^UTILITY(U,$J,358.3,22977,1,4,0)

 ;;=4^L01.00

 ;;^UTILITY(U,$J,358.3,22977,2)

 ;;=^5008938

 ;;^UTILITY(U,$J,358.3,22978,0)

 ;;=L03.90^^76^992^30

 ;;^UTILITY(U,$J,358.3,22978,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22978,1,3,0)

 ;;=3^Cellulitis

 ;;^UTILITY(U,$J,358.3,22978,1,4,0)

 ;;=4^L03.90

 ;;^UTILITY(U,$J,358.3,22978,2)

 ;;=^5009067

 ;;^UTILITY(U,$J,358.3,22979,0)

 ;;=Z79.1^^76^992^31

 ;;^UTILITY(U,$J,358.3,22979,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22979,1,3,0)

 ;;=3^Long Term Use NSAID/Oth Health Status

 ;;^UTILITY(U,$J,358.3,22979,1,4,0)

 ;;=4^Z79.1

 ;;^UTILITY(U,$J,358.3,22979,2)

 ;;=^5063332

 ;;^UTILITY(U,$J,358.3,22980,0)

 ;;=Z79.899^^76^992^32

 ;;^UTILITY(U,$J,358.3,22980,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22980,1,3,0)

 ;;=3^Long Term Use Oth Drug

 ;;^UTILITY(U,$J,358.3,22980,1,4,0)

 ;;=4^Z79.899

 ;;^UTILITY(U,$J,358.3,22980,2)

 ;;=^5063343

 ;;^UTILITY(U,$J,358.3,22981,0)

 ;;=Z80.8^^76^992^33

 ;;^UTILITY(U,$J,358.3,22981,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22981,1,3,0)

 ;;=3^Family Hx of Melanoma

 ;;^UTILITY(U,$J,358.3,22981,1,4,0)

 ;;=4^Z80.8

 ;;^UTILITY(U,$J,358.3,22981,2)

 ;;=^5063356

 ;;^UTILITY(U,$J,358.3,22982,0)

 ;;=Z48.817^^76^992^34

 ;;^UTILITY(U,$J,358.3,22982,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22982,1,3,0)

 ;;=3^Surgical Aftercare Skin/Subcutaneous Tissue

 ;;^UTILITY(U,$J,358.3,22982,1,4,0)

 ;;=4^Z48.817

 ;;^UTILITY(U,$J,358.3,22982,2)

 ;;=^5063054

 ;;^UTILITY(U,$J,358.3,22983,0)

 ;;=R99.^^76^992^35

 ;;^UTILITY(U,$J,358.3,22983,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22983,1,3,0)

 ;;=3^Dead Unknown Mortality

 ;;^UTILITY(U,$J,358.3,22983,1,4,0)

 ;;=4^R99.

 ;;^UTILITY(U,$J,358.3,22983,2)

 ;;=^5019750

 ;;^UTILITY(U,$J,358.3,22984,0)

 ;;=Z85.9^^76^992^36

 ;;^UTILITY(U,$J,358.3,22984,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22984,1,3,0)

 ;;=3^Personal Hx of Unspec Neoplasm/Cancer

 ;;^UTILITY(U,$J,358.3,22984,1,4,0)

 ;;=4^Z85.9

 ;;^UTILITY(U,$J,358.3,22984,2)

 ;;=^5063452

 ;;^UTILITY(U,$J,358.3,22985,0)

 ;;=C79.9^^76^992^37

 ;;^UTILITY(U,$J,358.3,22985,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22985,1,3,0)

 ;;=3^Metastatic Cancer Unspec

 ;;^UTILITY(U,$J,358.3,22985,1,4,0)

 ;;=4^C79.9

 ;;^UTILITY(U,$J,358.3,22985,2)

 ;;=^5133344

 ;;^UTILITY(U,$J,358.3,22986,0)

 ;;=Q3014^^77^993^1^^^^1

 ;;^UTILITY(U,$J,358.3,22986,1,0)

 ;;=^358.31IA^3^2

 ;;^UTILITY(U,$J,358.3,22986,1,2,0)

 ;;=2^Q3014

 ;;^UTILITY(U,$J,358.3,22986,1,3,0)

 ;;=3^Telehealth Fac Fee-Pt Site

 ;;^UTILITY(U,$J,358.3,22987,0)

 ;;=B19.10^^78^994^1

 ;;^UTILITY(U,$J,358.3,22987,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,22987,1,3,0)

 ;;=3^Hepatitis B w/o Hepatic Coma

 ;;^UTILITY(U,$J,358.3,22987,1,4,0)

 ;;=4^B19.10

 ;;^UTILITY(U,$J,358.3,22987,2)

 ;;=^5000552

 ;;^UTILITY(U,$J,358.3,22988,0)

 ;;=B17.10^^78^994^2

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI1F7   3746     printed  Feb 18, 2025@23:33:54                                                                                                                                                                                                    Page 2

IBDEI1F7  ; ; 01-FEB-2022

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 +2        if 'DIFQR(358.3)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.3,22975,1,3,0)

 +2       ;;=3^Purpura,Hemorrhagic Condition

 +3       ;;^UTILITY(U,$J,358.3,22975,1,4,0)

 +4       ;;=4^D69.8

 +5       ;;^UTILITY(U,$J,358.3,22975,2)

 +6       ;;=^88074

 +7       ;;^UTILITY(U,$J,358.3,22976,0)

 +8       ;;=L08.9^^76^992^28

 +9       ;;^UTILITY(U,$J,358.3,22976,1,0)

 +10      ;;=^358.31IA^4^2

 +11      ;;^UTILITY(U,$J,358.3,22976,1,3,0)

 +12      ;;=3^Pyoderma

 +13      ;;^UTILITY(U,$J,358.3,22976,1,4,0)

 +14      ;;=4^L08.9

 +15      ;;^UTILITY(U,$J,358.3,22976,2)

 +16      ;;=^5009082

 +17      ;;^UTILITY(U,$J,358.3,22977,0)

 +18      ;;=L01.00^^76^992^29

 +19      ;;^UTILITY(U,$J,358.3,22977,1,0)

 +20      ;;=^358.31IA^4^2

 +21      ;;^UTILITY(U,$J,358.3,22977,1,3,0)

 +22      ;;=3^Impetigo

 +23      ;;^UTILITY(U,$J,358.3,22977,1,4,0)

 +24      ;;=4^L01.00

 +25      ;;^UTILITY(U,$J,358.3,22977,2)

 +26      ;;=^5008938

 +27      ;;^UTILITY(U,$J,358.3,22978,0)

 +28      ;;=L03.90^^76^992^30

 +29      ;;^UTILITY(U,$J,358.3,22978,1,0)

 +30      ;;=^358.31IA^4^2

 +31      ;;^UTILITY(U,$J,358.3,22978,1,3,0)

 +32      ;;=3^Cellulitis

 +33      ;;^UTILITY(U,$J,358.3,22978,1,4,0)

 +34      ;;=4^L03.90

 +35      ;;^UTILITY(U,$J,358.3,22978,2)

 +36      ;;=^5009067

 +37      ;;^UTILITY(U,$J,358.3,22979,0)

 +38      ;;=Z79.1^^76^992^31

 +39      ;;^UTILITY(U,$J,358.3,22979,1,0)

 +40      ;;=^358.31IA^4^2

 +41      ;;^UTILITY(U,$J,358.3,22979,1,3,0)

 +42      ;;=3^Long Term Use NSAID/Oth Health Status

 +43      ;;^UTILITY(U,$J,358.3,22979,1,4,0)

 +44      ;;=4^Z79.1

 +45      ;;^UTILITY(U,$J,358.3,22979,2)

 +46      ;;=^5063332

 +47      ;;^UTILITY(U,$J,358.3,22980,0)

 +48      ;;=Z79.899^^76^992^32

 +49      ;;^UTILITY(U,$J,358.3,22980,1,0)

 +50      ;;=^358.31IA^4^2

 +51      ;;^UTILITY(U,$J,358.3,22980,1,3,0)

 +52      ;;=3^Long Term Use Oth Drug

 +53      ;;^UTILITY(U,$J,358.3,22980,1,4,0)

 +54      ;;=4^Z79.899

 +55      ;;^UTILITY(U,$J,358.3,22980,2)

 +56      ;;=^5063343

 +57      ;;^UTILITY(U,$J,358.3,22981,0)

 +58      ;;=Z80.8^^76^992^33

 +59      ;;^UTILITY(U,$J,358.3,22981,1,0)

 +60      ;;=^358.31IA^4^2

 +61      ;;^UTILITY(U,$J,358.3,22981,1,3,0)

 +62      ;;=3^Family Hx of Melanoma

 +63      ;;^UTILITY(U,$J,358.3,22981,1,4,0)

 +64      ;;=4^Z80.8

 +65      ;;^UTILITY(U,$J,358.3,22981,2)

 +66      ;;=^5063356

 +67      ;;^UTILITY(U,$J,358.3,22982,0)

 +68      ;;=Z48.817^^76^992^34

 +69      ;;^UTILITY(U,$J,358.3,22982,1,0)

 +70      ;;=^358.31IA^4^2

 +71      ;;^UTILITY(U,$J,358.3,22982,1,3,0)

 +72      ;;=3^Surgical Aftercare Skin/Subcutaneous Tissue

 +73      ;;^UTILITY(U,$J,358.3,22982,1,4,0)

 +74      ;;=4^Z48.817

 +75      ;;^UTILITY(U,$J,358.3,22982,2)

 +76      ;;=^5063054

 +77      ;;^UTILITY(U,$J,358.3,22983,0)

 +78      ;;=R99.^^76^992^35

 +79      ;;^UTILITY(U,$J,358.3,22983,1,0)

 +80      ;;=^358.31IA^4^2

 +81      ;;^UTILITY(U,$J,358.3,22983,1,3,0)

 +82      ;;=3^Dead Unknown Mortality

 +83      ;;^UTILITY(U,$J,358.3,22983,1,4,0)

 +84      ;;=4^R99.

 +85      ;;^UTILITY(U,$J,358.3,22983,2)

 +86      ;;=^5019750

 +87      ;;^UTILITY(U,$J,358.3,22984,0)

 +88      ;;=Z85.9^^76^992^36

 +89      ;;^UTILITY(U,$J,358.3,22984,1,0)

 +90      ;;=^358.31IA^4^2

 +91      ;;^UTILITY(U,$J,358.3,22984,1,3,0)

 +92      ;;=3^Personal Hx of Unspec Neoplasm/Cancer

 +93      ;;^UTILITY(U,$J,358.3,22984,1,4,0)

 +94      ;;=4^Z85.9

 +95      ;;^UTILITY(U,$J,358.3,22984,2)

 +96      ;;=^5063452

 +97      ;;^UTILITY(U,$J,358.3,22985,0)

 +98      ;;=C79.9^^76^992^37

 +99      ;;^UTILITY(U,$J,358.3,22985,1,0)

 +100     ;;=^358.31IA^4^2

 +101     ;;^UTILITY(U,$J,358.3,22985,1,3,0)

 +102     ;;=3^Metastatic Cancer Unspec

 +103     ;;^UTILITY(U,$J,358.3,22985,1,4,0)

 +104     ;;=4^C79.9

 +105     ;;^UTILITY(U,$J,358.3,22985,2)

 +106     ;;=^5133344

 +107     ;;^UTILITY(U,$J,358.3,22986,0)

 +108     ;;=Q3014^^77^993^1^^^^1

 +109     ;;^UTILITY(U,$J,358.3,22986,1,0)

 +110     ;;=^358.31IA^3^2

 +111     ;;^UTILITY(U,$J,358.3,22986,1,2,0)

 +112     ;;=2^Q3014

 +113     ;;^UTILITY(U,$J,358.3,22986,1,3,0)

 +114     ;;=3^Telehealth Fac Fee-Pt Site

 +115     ;;^UTILITY(U,$J,358.3,22987,0)

 +116     ;;=B19.10^^78^994^1

 +117     ;;^UTILITY(U,$J,358.3,22987,1,0)

 +118     ;;=^358.31IA^4^2

 +119     ;;^UTILITY(U,$J,358.3,22987,1,3,0)

 +120     ;;=3^Hepatitis B w/o Hepatic Coma

 +121     ;;^UTILITY(U,$J,358.3,22987,1,4,0)

 +122     ;;=4^B19.10

 +123     ;;^UTILITY(U,$J,358.3,22987,2)

 +124     ;;=^5000552

 +125     ;;^UTILITY(U,$J,358.3,22988,0)

 +126     ;;=B17.10^^78^994^2